Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-20

Clinical Trial Update: A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen [Phase 2]

View source ↗

Summary

Phase 2 trial comparing levocetirizine to placebo for reducing seasonal allergic rhinitis symptoms in ragweed-exposed subjects; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levocetirizine (Levocetirizine)

Snippet

Sponsor: UCB Pharma | Conditions: Rhinitis, Allergic | Phase 2 | Status: COMPLETED | Results posted: 2018-07-20